569 related articles for article (PubMed ID: 8408652)
21. The orphan receptor TAK1 acts as a repressor of RAR-, RXR- and T3R-mediated signaling pathways.
Hirose T; Apfel R; Pfahl M; Jetten AM
Biochem Biophys Res Commun; 1995 Jun; 211(1):83-91. PubMed ID: 7779113
[TBL] [Abstract][Full Text] [Related]
22. Understanding the molecular mechanism of dominant negative action of mutant thyroid hormone beta 1-receptors: the important role of the wild-type/mutant receptor heterodimer.
Zhu XG; Yu CL; McPhie P; Wong R; Cheng SY
Endocrinology; 1996 Feb; 137(2):712-21. PubMed ID: 8593822
[TBL] [Abstract][Full Text] [Related]
23. Roles of 3,5,3'-triiodothyronine and deoxyribonucleic acid binding on thyroid hormone receptor complex formation.
Yen PM; Brubaker JH; Apriletti JW; Baxter JD; Chin WW
Endocrinology; 1994 Mar; 134(3):1075-81. PubMed ID: 8119145
[TBL] [Abstract][Full Text] [Related]
24. Critical role of glutamine 252 in the hormone-dependent transcriptional activity of the thyroid hormone beta1 nuclear receptor.
Bhat MK; McPhie P; Cheng S
Biochemistry; 1997 Apr; 36(14):4233-9. PubMed ID: 9100018
[TBL] [Abstract][Full Text] [Related]
25. Requirement of corepressor binding of thyroid hormone receptor mutants for dominant negative inhibition.
Nagaya T; Fujieda M; Seo H
Biochem Biophys Res Commun; 1998 Jun; 247(3):620-3. PubMed ID: 9647743
[TBL] [Abstract][Full Text] [Related]
26. Sick euthyroid syndrome is associated with decreased TR expression and DNA binding in mouse liver.
Beigneux AP; Moser AH; Shigenaga JK; Grunfeld C; Feingold KR
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E228-36. PubMed ID: 12388159
[TBL] [Abstract][Full Text] [Related]
27. Cell type-dependent modulation of the dominant negative action of human mutant thyroid hormone beta 1 receptors.
Wong R; Zhu XG; Pineda MA; Cheng SY; Weintraub BD
Mol Med; 1995 Mar; 1(3):306-19. PubMed ID: 8529109
[TBL] [Abstract][Full Text] [Related]
28. Analysis of structure and expression of the Xenopus thyroid hormone receptor-beta gene to explain its autoinduction.
Machuca I; Esslemont G; Fairclough L; Tata JR
Mol Endocrinol; 1995 Jan; 9(1):96-107. PubMed ID: 7760854
[TBL] [Abstract][Full Text] [Related]
29. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone.
Safer JD; Langlois MF; Cohen R; Monden T; John-Hope D; Madura J; Hollenberg AN; Wondisford FE
Mol Endocrinol; 1997 Jan; 11(1):16-26. PubMed ID: 8994184
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
[TBL] [Abstract][Full Text] [Related]
31. Dominant-negative mutant thyroid hormone receptors prevent transcription from Xenopus thyroid hormone receptor beta gene promoter in response to thyroid hormone in Xenopus tadpoles in vivo.
Ulisse S; Esslemont G; Baker BS; Krishna V; Chatterjee K; Tata JR
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1205-9. PubMed ID: 8577741
[TBL] [Abstract][Full Text] [Related]
32. Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone.
Takeda T; Suzuki S; Liu RT; DeGroot LJ
J Clin Endocrinol Metab; 1995 Jul; 80(7):2033-40. PubMed ID: 7608251
[TBL] [Abstract][Full Text] [Related]
33. Difference in dominant negative activities between mutant thyroid hormone receptors alpha1 and beta1 with an identical truncation in the extreme carboxyl-terminal tau4 domain.
Nishiyama K; Andoh S; Kitahara A; Natsume H; Mikami T; Genma R; Nakamura H
Mol Cell Endocrinol; 1998 Mar; 138(1-2):95-104. PubMed ID: 9685218
[TBL] [Abstract][Full Text] [Related]
34. Retinoid X receptor-alpha and apolipoprotein AI regulatory protein 1 differentially modulate 3,5,3'-triiodothyronine-induced transcription.
Rhee M; Ikeda M; Chin WW
Endocrinology; 1995 Jun; 136(6):2697-704. PubMed ID: 7750494
[TBL] [Abstract][Full Text] [Related]
35. Ligand (T3) dependent and independent effects of thyroid hormone receptors upon human TRH gene transcription in neuroblastoma cells.
Feng P; Li QL; Satoh T; Wilber JF
Biochem Biophys Res Commun; 1994 Apr; 200(1):171-7. PubMed ID: 8166684
[TBL] [Abstract][Full Text] [Related]
36. Homodimer and heterodimer DNA binding and transcriptional responsiveness to triiodothyronine (T3) and 9-cis-retinoic acid are determined by the number and order of high affinity half-sites in a T3 response element.
Force WR; Tillman JB; Sprung CN; Spindler SR
J Biol Chem; 1994 Mar; 269(12):8863-71. PubMed ID: 8132622
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone beta-receptors in thyroid hormone resistance syndrome.
Collingwood TN; Adams M; Tone Y; Chatterjee VK
Mol Endocrinol; 1994 Sep; 8(9):1262-77. PubMed ID: 7838159
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation enhances the target gene sequence-dependent dimerization of thyroid hormone receptor with retinoid X receptor.
Bhat MK; Ashizawa K; Cheng SY
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):7927-31. PubMed ID: 8058736
[TBL] [Abstract][Full Text] [Related]
39. Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma.
Lin KH; Zhu XG; Hsu HC; Chen SL; Shieh HY; Chen ST; McPhie P; Cheng SY
Endocrinology; 1997 Dec; 138(12):5308-15. PubMed ID: 9389515
[TBL] [Abstract][Full Text] [Related]
40. Dominant negative transcriptional regulation by a mutant thyroid hormone receptor-beta in a family with generalized resistance to thyroid hormone.
Sakurai A; Miyamoto T; Refetoff S; DeGroot LJ
Mol Endocrinol; 1990 Dec; 4(12):1988-94. PubMed ID: 2082193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
